You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: June 20, 2025

Drugs Containing Excipient (Inactive Ingredient) ANHYDROUS DIBASIC CALCIUM PHOSPHATE


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE excipient, and estimated key patent expiration / generic entry dates

Generic drugs containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE excipient

Market Dynamics and Financial Trajectory for Anhydrous Dibasic Calcium Phosphate

Market Overview

Anhydrous dibasic calcium phosphate, a crucial pharmaceutical excipient, is experiencing significant growth driven by various market dynamics. Here’s a detailed look at the current state and future projections of this market.

Market Size and Growth

The global anhydrous dibasic calcium phosphate market was valued at US$ 213.5 million in 2023 and is projected to reach US$ 315.1 million by 2030, growing at a Compound Annual Growth Rate (CAGR) of 5.7% during the forecast period (2023-2030)[1][2].

Drivers of Market Growth

Increasing Demand for Dietary Supplements

The rising health awareness and the growing consumption of dietary supplements are major drivers of the market. The increasing geriatric population, which is expected to reach 1.4 billion by 2030, drives the demand for food supplements and pharmaceutical products that contain anhydrous dibasic calcium phosphate[1].

Pharmaceutical Applications

Anhydrous dibasic calcium phosphate is widely used as a binder and filler in solid oral dosage forms, including compressed tablets and hard gelatin capsules. Its excellent flowability and compressibility characteristics make it a popular choice in the pharmaceutical industry. Products like Benadryl, Sudafed, and Norvasc often contain this excipient[3].

Animal Feed and Agriculture

The compound is also used extensively in animal feed to promote animal health, growth, and nutrition. The growing livestock industry, particularly in regions like North America and Asia-Pacific, further boosts the demand for anhydrous dibasic calcium phosphate[4].

Market Segmentation

By Source

The market is segmented into hydrochloric acid and phosphoric acid sources. The hydrochloric acid segment is expected to dominate due to the increasing availability of anhydrous dibasic calcium phosphate obtained from this source[1][2].

By End Use

The market is segmented into animal feed, food & beverage, agriculture, pharmaceutical, and others. The pharmaceutical segment is anticipated to dominate the market over the forecast period due to the increasing demand for pharmaceutical products[1][2].

By Region

The market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. Asia Pacific is expected to be the dominant region due to increasing manufacturing activities and a large consumer base[1].

Restraints and Challenges

High Cost

The high cost of anhydrous dibasic calcium phosphate is a significant restraint. The costs of phosphoric acid and calcium oxide, key ingredients in its formation, have increased due to factors like surging input costs, supply disruptions, and export restrictions. This has raised concerns about affordability and availability[1].

Supply Chain Disruptions

The COVID-19 pandemic had a negative impact on the market due to reduced manufacturing and supply of drugs and excipients. Lockdowns, travel restrictions, and shortages of raw materials and workers further exacerbated the supply chain disruptions[1].

Regulatory Challenges

Strict regulations on the use of dibasic calcium phosphate can also hamper market growth. Compliance with evolving regulations, especially in regions like North America, is crucial for market players[2].

Key Players and Market Strategies

Major players in the global anhydrous dibasic calcium phosphate market include CAP Biomaterials, LLC, Kemapco Arab Fertilizers & Chemicals Industries LTD, Merck KGaA, AARTI INDUSTRIES LIMITED, and others. These companies are focusing on research and development, acquisitions, and collaborative agreements to strengthen their market positions.

For instance, the Mosaic Company's acquisition of Vale Fertilizantes in 2018 aimed to expand its phosphate fertilizer production capacity. Similarly, the collaboration between EuroChem Group and Aphea.Bio for R&D of next-gen fertilizer technologies is another strategic move to drive market growth[2].

Launch of New Products

The launch of new products containing anhydrous dibasic calcium phosphate, such as Shijiazhuang Junlebao Dairy Co., Ltd.'s milk powder targeted at supporting calcium absorption in middle and old-aged consumers, is expected to drive market growth. Such innovations improve bioaccessibility and bioavailability, rejuvenating established categories[1].

Regional Insights

North America

North America is expected to account for a significant market share due to improving product qualities and evolving regulations. The region's advanced and well-developed livestock industry, particularly in the U.S. and Canada, drives the demand for anhydrous dibasic calcium phosphate in animal feed[2].

Asia Pacific

The Asia Pacific region is growing rapidly due to its substantial livestock population, expanding disposable income, and large consumer base. Countries like China and India are driving the demand for high-quality animal feed, which in turn boosts the market for anhydrous dibasic calcium phosphate[4].

Europe

In Europe, the expanding prevalence of sustainable agriculture and organic farming is driving the market. The European Green Deal's focus on achieving zero net greenhouse gas emissions by 2050 and the growing geriatric population in the region are expected to enhance market growth[4].

Financial Trajectory

The financial trajectory of the anhydrous dibasic calcium phosphate market is positive, with a projected CAGR of 5.7% from 2023 to 2030. Here are some key financial highlights:

  • Market Size: Expected to grow from US$ 213.5 million in 2023 to US$ 315.1 million by 2030[1].
  • Revenue Growth: Driven by increasing demand in pharmaceutical, animal feed, and food & beverage sectors.
  • Investment Opportunities: Companies are investing in R&D and strategic acquisitions to expand their market presence and production capacities[2].

Key Takeaways

  • The global anhydrous dibasic calcium phosphate market is driven by the growing demand for dietary supplements and pharmaceutical products.
  • The pharmaceutical segment is expected to dominate the market due to its extensive use as a binder and filler in solid oral dosage forms.
  • Asia Pacific is anticipated to be the dominant region due to its large consumer base and growing livestock industry.
  • High costs and supply chain disruptions are significant restraints that need to be addressed.
  • Key players are focusing on R&D, acquisitions, and collaborative agreements to drive market growth.

FAQs

Q: What is the projected market size of anhydrous dibasic calcium phosphate by 2030?

The global anhydrous dibasic calcium phosphate market is projected to reach US$ 315.1 million by 2030[1].

Q: What are the main drivers of the anhydrous dibasic calcium phosphate market?

The main drivers include the increasing demand for dietary supplements, growing health awareness, and the extensive use in pharmaceutical and animal feed applications[1][2].

Q: Which region is expected to dominate the anhydrous dibasic calcium phosphate market?

Asia Pacific is expected to be the dominant region due to its large consumer base and growing livestock industry[1].

Q: What are the significant restraints facing the anhydrous dibasic calcium phosphate market?

High costs, supply chain disruptions, and strict regulations are significant restraints facing the market[1][2].

Q: Who are the major players in the anhydrous dibasic calcium phosphate market?

Major players include CAP Biomaterials, LLC, Kemapco Arab Fertilizers & Chemicals Industries LTD, Merck KGaA, AARTI INDUSTRIES LIMITED, and others[1][2].

Sources

  1. Coherent Market Insights: Anhydrous Dibasic Calcium Phosphate Market Size & Share Analysis.
  2. Business Wire: Global Anhydrous Dibasic Calcium Phosphate Market to Surpass US$ 254.7 Million by 2027.
  3. Texas A&M University: Calcium Phosphate in Pharmaceutical Product Development.
  4. Straits Research: Dicalcium Phosphate Market Size, Share & Analysis to 2031.
Last updated: 2024-12-17

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.